1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
CuraScientific Corp

CuraScientific Corp

CSTF
CuraScientific CorpUS flagOther OTC
0.00
USD
- -
- -
377,345.00Market Cap

Total Valuation

CuraScientific Corp carries a market capitalization of 377,345.00, placing it among publicly traded companies globally. Its enterprise value stands at 38.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap377,345.00
Enterprise Value38.37M

Share Statistics

CuraScientific Corp currently has 2.63B shares outstanding.

Shares Outstanding2.63B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

CuraScientific Corp trades at a trailing price-to-earnings ratio of 1.12. The price-to-sales ratio is 56.10, and the price-to-book ratio stands at 2.14.

PE Ratio1.12
PS Ratio56.10
PB Ratio2.14
P/TBV Ratio-1.51
P/FCF Ratio-190.00
P/OCF Ratio-123.81

Enterprise Valuation

EV / Sales57.13
EV / EBITDAN/A
EV / EBITN/A
EV / FCF1,118.78

Financial Position

CuraScientific Corp maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2.96, indicating conservative leverage, while an interest coverage ratio of -14.14 demonstrates limited ability to service its debt obligations.

Current Ratio0.04
Quick Ratio0.00
Debt / Equity-2.96
Debt / EBITDA-0.25
Interest Coverage-14.14

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)2,028.95
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)1,043.88
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover11.63

Stock Price Statistics

CuraScientific Corp's stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change0.000003%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, CuraScientific Corp generated 671,651.00 in revenue and converted that into 33.68M in net income, yielding earnings per share of 0.11. EBITDA reached -2.88M, while operating income came in at -2.91M.

Revenue671,651.00
Gross Profit331,364.00
Operating Income-2.91M
Pretax Income33.68M
Net Income33.68M
EBITDA-2.88M
EBIT-2.91M
Earnings Per Share (EPS)0.11

Balance Sheet

CuraScientific Corp holds 40,911.00 in cash and equivalents against 733,931.00 in total debt, resulting in a net debt position of 577,124.00. Total book value stands at 17.58M, with working capital of -24.98M providing operational flexibility.

Cash & Cash Equivalents40,911.00
Total Debt733,931.00
Net Debt577,124.00
Equity (Book Value)17.58M
Book Value Per Share0.06
Working Capital-24.98M

Cash Flow

CuraScientific Corp produced -304,302.00 in operating cash flow over the past twelve months. After subtracting -97,686.00 in capital expenditures, free cash flow totaled -401,988.00 - equivalent to 0.00 per share.

Operating Cash Flow-304,302.00
Capital Expenditures-97,686.00
Free Cash Flow-401,988.00
FCF Per Share0.00

Margins

CuraScientific Corp operates with a gross margin of 49.34, reflecting its pricing power and cost economics. The operating margin of -432.79 and net profit margin of 5,015.07 provide insight into operational efficiency.

Gross Margin49.34
Operating Margin-432.79
Pretax Margin5,015.07
Profit Margin5,015.07
EBITDA Margin-429.50

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.97
FCF Yield-0.53

Stock Splits

CuraScientific Corp's most recent stock split took place on April 24, 2023 with a 500:1 split ratio.

Last Split Date4/24/2023
Split Ratio500:1

Scores

CuraScientific Corp posts an Altman Z-Score of -9.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.86